Close on 09 Oct 2026
All Indian Equities

ASARFI HOSPITAL

ASARFIVerified
ISIN: BSE:543943 · Exchange: BSE

ASARFI HOSPITAL is a publicly traded security listed on the BSE exchange.

Sector: Diversified Indian Equities·Industry: Public Market Listed Security·Market Cap: LARGE CAP
Close on 16 Oct 2026
₹191.45
+5.45 (+2.93%)
Last updated: 16 Oct 2026 (NSE/BSE EOD settlement)

Stock Snapshot & Key Numbers — ASARFI HOSPITAL

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +2.93% on 16 Oct 2026
Position vs 1-Year High
24.3% below 52W High
P/E Valuation Multiple
22.2x (20x–40x range)
Annual Cash Dividend
0.00% / No Recent Dividend
Close on 16 Oct 2026
₹191.45
+5.45 (+2.93%)vs prev close
1-Year Low to High Range52% of range
Low: ₹126High: ₹253
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):22.2x
P/B Ratio (Price / Book):3.9x
Dividend Yield:0.00%
Total Company Value (Market Cap)
₹394.83 Cr
Sector: Diversified Indian Equities
Latest Official Announcement:Asarfi Hospital Credit Rating Upgraded to CRISIL BBB/Stable on Improved Earnings - Whalesbook
9d ago
Plain-English Company Summary

ASARFI HOSPITAL (ASARFI) is a Indian equity security listed on the BSE with ISIN BSE:543943. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹191.45, recording a +5.45 (+2.93%) advance from its previous close of ₹186.00. Over the trailing 52-week trading cycle, ASARFI has traded between a 52-week low of ₹125.80 and a 52-week high of ₹252.80, establishing its annual trading channel. In historical performance, ASARFI HOSPITAL has gained 39.74% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -4.59%, 1-month: +3.35%, 6-month: -9.48%, 1-year: +39.74%, 3-year: +77.84%, 5-year: +84.55%. Daily reported trading volume reached 42,000 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 22.2x and a price-to-book (P/B) ratio of 3.9x, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹394.83 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.

Price Chart

1Y: +39.74% (₹54.45)
₹253₹213₹175₹136Thu, 16 Oct, 2025Fri, 16 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Channel₹191.45
Low: ₹125.8High: ₹252.8
Day Range₹186 – ₹196
Market Cap₹394.83 Cr
Reported Volume42,000
P/E Ratio (TTM)22.2x
Price-to-Book (P/B)3.9x
Dividend Yield0.00%
Fundamentals as of 11 Oct 2026

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
773 past 21-day periods analyzed
Fell 38.3%
Within ±5% (26.3%)
Rose 35.4%
Fell > 5%
38.3%
296 windows
Within ±5%
26.3%
203 windows
Rose > 5%
35.4%
274 windows
In 80% of past 1 month windows the move was within ±19.7%.
Historical outcomes of this stock's own price. Not a forecast. (794 trading days of history).
How to read historical odds

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 55.0% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
NIFTY 50+1.02+0.25Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +1.02% co-movement (correlation: 0.25). Descriptive historical relationship, not predictive.
USD / INR-0.70-0.10Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.70% co-movement (correlation: -0.10). Descriptive historical relationship, not predictive.
Brent Crude Oil+0.03+0.03Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a +0.03% co-movement (correlation: 0.03). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield+0.15+0.04Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a +0.15% co-movement (correlation: 0.04). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹200.65₹191.45-4.59%
15 Days₹177.00₹191.45+8.16%
1 Month₹185.25₹191.45+3.35%
3 Months₹220.00₹191.45-12.98%
6 Months₹211.50₹191.45-9.48%
1 Year₹137.00₹191.45+39.74%
3 Years₹107.65₹191.45+77.84%
5 Years₹103.74₹191.45+84.55%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
55.0%
Annualized volatility
1Y Beta vs Index
1.00
vs benchmark index
Biggest 1Y Drop
-34.6%
1Y peak-to-low drop
Biggest 5Y Drop
-60.9%
5Y peak-to-low drop
vs 52W High
-24.3%
Distance from 1Y high
vs 52W Low
+52.2%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹184.90₹191.45+3.5%
CY 2025₹99.97₹188.10+88.2%
CY 2024₹82.85₹99.75+20.4%
CY 2023₹103.74₹85.00-18.1%

Historical Investment Simulator

Factual simulation of past returns in ASARFI HOSPITAL (ASARFI) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹1,84,547.91
Based on latest close
Absolute Return
+84.5%
+₹84,547.91
Annualized (CAGR)
+20.9%
Compound annual growth
Entry Price: ₹103.74 · Exit Price: ₹191.45
Simulated 5Y period (INR)

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for ASARFI.

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 5 of 10 Updates
#1 GOVERNMENT POLICY INFRALODR Materiality: 99/100Positive Business DriverRecent EventDirect Mention
9d ago

Asarfi Hospital Credit Rating Upgraded to CRISIL BBB/Stable on Improved Earnings - Whalesbook

Asarfi Hospital Credit Rating Upgraded to CRISIL BBB/Stable on Improved Earnings Whalesbook

Valuation Impact:+3.5% to +8.0% (Sovereign Defence Contract Accretion)
Inspecting in Causal Panel
Source: Whalesbook·Horizon: MEDIUM_TERM
SEBI LODR Reg 30 Mapped
#2 GOVERNMENT POLICY INFRALODR Materiality: 99/100Positive Business DriverRecent EventDirect Mention
9d ago

Asarfi Hospital: रेटिंगमध्ये मोठी सुधारणा, नफ्याचा वेग वाढल्याने CRISIL कडून रेटिंग 'अपग्रेड' - Whalesbook

Asarfi Hospital: रेटिंगमध्ये मोठी सुधारणा, नफ्याचा वेग वाढल्याने CRISIL कडून रेटिंग 'अपग्रेड' Whalesbook

Valuation Impact:+3.5% to +8.0% (Sovereign Defence Contract Accretion)
Click to analyze
Source: Whalesbook·Horizon: MEDIUM_TERM
SEBI LODR Reg 30 Mapped
#3 EARNINGSLODR Materiality: 99/100Positive Business DriverBackground ContextDirect Mention
5mo ago

Asarfi Hospital Reports 42% FY26 Revenue Growth; Audited Results Published in National Newspapers - scanx.trade

Asarfi Hospital Reports 42% FY26 Revenue Growth; Audited Results Published in National Newspapers scanx.trade

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Click to analyze
Source: scanx.trade·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#4 EARNINGSLODR Materiality: 91/100Neutral / RoutineBackground ContextDirect Mention
2mo ago

Asarfi Hospital targets ₹400 crore revenue by FY28 - scanx.trade

Asarfi Hospital targets ₹400 crore revenue by FY28 scanx.trade

Valuation Impact:±1.0% (In-line Quarterly Disclosure)
Outlay:₹400 Cr
Click to analyze
Source: scanx.trade·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#5 GENERALLODR Materiality: 68/100Neutral / RoutineOngoing ImpactDirect Mention
29d ago

Asarfi Hospital shareholders approve NSE listing, BSE migration at AGM - scanx.trade

Asarfi Hospital shareholders approve NSE listing, BSE migration at AGM scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 5
Causal Attribution in Focus
GOVERNMENT POLICY INFRA·9d ago
Verified Exchange / Wire Disclosure:
Asarfi Hospital Credit Rating Upgraded to CRISIL BBB/Stable on Improved Earnings - Whalesbook
Source: Whalesbook·LODR Materiality: 99/100Tailwind
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Government Infrastructure Sanction & Capex Policy
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. ASARFI Accretion
+3.5% to +8.0% (Sovereign Defence Contract Accretion)
Causal Attribution Analysis:Direct Named Awardee

Ministry of Defence capital acquisitions under Positive Indigenisation lists grant high-margin, sovereign counterparty contracts with multi-year revenue locking.

Extracted Factual Evidence:
  • •Atmanirbhar Bharat defence procurement mandate sanctions domestic equipment contracts
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Defence Order BacklogEBITDA Margin VisibilitySovereign Milestone Advances
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

At-a-Glance Health & Momentum Check

Market Mood: Expansionary / Momentum
News Activity
ACCELERATING
Recent announcement pace
Profit & Margin Trend
NEUTRAL
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Expansionary / Momentum
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.

Active Risk Flags & Monitoring Constraints
Elevated regulatory and disclosure event clustering in observation window

Peer & Sector Comparison — Next Research Steps

Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.

Explore All Equities
Same-Sector Peers
Diversified Indian Equities
No direct peers in sector coverage.
Same-Industry Peers
Industry Sub-Segment
No peer equities in this industry.
Also Viewed In Session
Recent History
Start browsing to build your active session footprint.

Common Questions About ASARFI HOSPITAL (ASARFI)

Key facts on ASARFI share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of ASARFI HOSPITAL (ASARFI)?

As of 16 Oct 2026, the official closing share price of ASARFI HOSPITAL (ASARFI) on BSE is ₹191.45 (+2.93% vs the previous close). Over the past 52 weeks, ASARFI has traded between a low of ₹125.80 and a high of ₹252.80, with a reported market capitalization of ₹394.83 Cr.

What are the historical returns of ASARFI HOSPITAL (ASARFI)?

Based on split-adjusted closing prices through 16 Oct 2026, ASARFI HOSPITAL (ASARFI) recorded the following trailing price returns: 1 Week: -4.59% (from ₹200.65 to ₹191.45); 15 Days: +8.16% (from ₹177.00 to ₹191.45); 1 Month: +3.35% (from ₹185.25 to ₹191.45); 3 Months: -12.98% (from ₹220.00 to ₹191.45); 6 Months: -9.48% (from ₹211.50 to ₹191.45); 1 Year: +39.74% (from ₹137.00 to ₹191.45); 3 Years: +77.84% (from ₹107.65 to ₹191.45); 5 Years: +84.55% (from ₹103.74 to ₹191.45). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of ASARFI HOSPITAL (ASARFI)?

ASARFI HOSPITAL (ASARFI) currently trades at a trailing Price-to-Earnings (P/E) ratio of 22.2x, a Price-to-Book (P/B) ratio of 3.9x, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).

How much would a past lump-sum or monthly SIP investment in ASARFI have grown?

Based on historical closing prices for ASARFI HOSPITAL (ASARFI): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹1,84,547.91 (+84.5% total return, 20.9% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹4,00,000.00) would be worth ₹7,16,177.66 (+79.0% absolute return). You can test custom amounts and holding periods in the interactive calculator above.

Official Corporate Perspective

No authenticated statement registered for ASARFI.

Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.

Independent exchange feeds and algorithmic models cannot be edited or suppressed by corporate submissions.